DiscoverLung Cancer ConsideredLCC In Italian--First-Line Treatment Options for EGFR Mutant NSCLC
LCC In Italian--First-Line Treatment Options for EGFR Mutant NSCLC

LCC In Italian--First-Line Treatment Options for EGFR Mutant NSCLC

Update: 2024-06-20
Share

Description

This episode of Lung Cancer Considered discusses first-line treatment options for EGFR mutant NSCLC, in Italian.

Guest: Dr. Jessica Menis is a thoracic medical oncologist with expertise in early-phase trials and drug development from Azienda Ospedaliera Universitaria Integrata Verona. Jessica, welcome to the podcast.


Guest: Professor Filippo de Marinis is from Istituto Europeo di Oncologia, where he is Direttore della Divisione di Oncologia Toracica, and the president of Associazione Italiana Oncologia Toracica.
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

LCC In Italian--First-Line Treatment Options for EGFR Mutant NSCLC

LCC In Italian--First-Line Treatment Options for EGFR Mutant NSCLC

IASLC